COSMOS

Professor Price is Primary Care Respiratory Society Professor of Primary Care Respiratory Medicine at the University of Aberdeen (UK). He was awarded Fellow of ERS (FERS) in 2016. He is also a member of the World Health Organization (WHO) Allergic Rhinitis and its Impact on Asthma (ARIA) executive committee, the World Allergy Organization (WAO), Committee on Asthma, and the WAO Education Council.

Professor Price was the founding president of the Respiratory Effectiveness Group (http://www.effectivenessevaluation.org/), a not-for-profit, investigator-led initiative which uses an international collaborative approach to explore the optimum role of real-life research in informing clinical guidelines and improving patient care.

Professor Price completed his medical degree at Cambridge University in 1984. He was previously Affiliate Associate Professor in the Department of General Practice at the University of Adelaide, Australia and held an Honorary Chair at the University of East Anglia, UK.

He is extensively involved in respiratory and allergy research; his areas of special interest are the ‘real-life’ effectiveness and cost-effectiveness of interventions, clinical trial design, adherence, and patient attitudes to their disease. He has authored more than 490 peer-reviewed publications and is responsible for approximately US$50 million in research and clinical development grants. He is currently Editor-in-Chief of the journal Pragmatic and Observational Research and member of the editorial board of several respiratory journals, including The Lancet Respiratory Medicine.

Vall d’Hebron University Hospital and the Vall d’Hebron Research Institute (VHIR) in Barcelona, Spain.

I obtained my MD at the Universitat de Barcelona, Barcelona, Spain in 1986 and my PhD at the Universitat Autònoma de Bacelona in 1997. He trained as specialist in Respiratory Medicine at Vall d'Hebron Hospital. Hisprimary research interests include chronic obstructive pulmonary disease (COPD), alpha-1-antitrypsin deficiency (AAT), lung defence mechanisms and respiratory infections. Dr Miravitlles served as Secretary General of the Spanish Society of Pneumology and Thoracic Surgery (SEPAR) from 1999 to 2003 and  was responsible for International Relationships of SEPAR from 2006 until 2012. Dr Miravitlles was Chair of the Respiratory Infections Group of the European Respiratory Society (ERS) from 2008 to 2011 and  was the Guidelines Director of the ERS from 2015 to 2018.

Dr Miravitlles has acted as a consultant and/or chair or author for the development of different international guidelines of COPD, including the American Thoracic Society (ATS)/ERS task force on outcomes in COPD, the ERS/ATS guidelines on diagnostic and treatment of exacerbations of COPD and the ERS statement on management of alpha-1 antitrypsin deficiency. Dr Miravitlles is also a consultant of the Spanish Ministry of Health for the development of the National Strategy Against COPD (2009 to present) and coordinator of the Spanish National Guidelines for COPD (GesEPOC from 2012). Dr Miravitlles is the director of the reference center for diagnosis and treatment of AATD in the Hospital Vall d’Hebron and the author of 498 publications listed in PubMed and a h-index of 73 (May 2020)

Fernando is a Regents’ Professor and Director of the Asthma & Airway Disease Research Center at the University of Arizona in Tucson. Dr. Martinez is a world-renowned expert, and one of the most highly regarded researchers, in the field of childhood asthma. His primary research interests are the natural history, genetics, and treatment of childhood asthma. His groundbreaking research has had an impact on his field in numerous ways, most prominent among them the development of the concept of the early origins of asthma and COPD. This concept is now widely accepted as the potential basis for the design of new strategies for the prevention of these devastating illnesses affecting millions of children and adults worldwide. In addition, Dr. Martinez has made important contributions to our understanding of the role of gene-environment interactions in the development of asthma and allergies.

He has also been the principal investigator of one of the Clinical Centers that are part of the NHLBI Asthma Treatment Networks, which have contributed fundamental new evidence on which to base national guidelines for the treatment of the disease. Dr. Martinez currently serves on the National Scientific Council on the Developing Child, and was a board member for the NHLBI National Advisory Council for 3 years. He was a member of the National Asthma Education and Prevention Program that was responsible for the development of the Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma in 1997 and its first revision in 2001. He also has been a member of the FDA Pulmonary-Allergy Drugs Advisory Committee and the Board of Extramural Advisors of the National Heart, Lung, and Blood Institute (NHLBI).

Dr. Martinez’s research and vision are well detailed in more than 250 original research papers and editorials, many in collaboration with investigators from all over the world. He is frequently invited to give keynote presentations at national and international meetings.

Rongchang Chen is the director of the Shenzhen Institute of Respiratory Diseases at Shenzhen People's Hospital. His expertise lies in respiratory and critical care medicine, and he has made significant contributions to the management of various respiratory diseases, including COPD and COVID-19.

Dr. Chen has an extensive research background and has authored numerous publications on non-invasive ventilation and other respiratory therapies. He is affiliated with several prestigious institutions, including the State Key Laboratory of Respiratory Disease and the National Clinical Research Center for Respiratory Disease.

Katherine qualified from Leeds University in 2000. She originally did a Medicine Rotation acquiring her MRCP before settling into General Practice. She is a GP Partner in Bradford. Over the years Katherine has developed a keen interest in Respiratory medicine and is Respiratory Lead for West Yorkshire and Harrogate Health and Care Partnership. She also works extensively with the Primary Care Respiratory Society. Outside of work Katherine spends most of her time running around after her three children. She also enjoys baking, yoga and has recently rediscovered her love for singing and joined a choir.

Prof Wilkinson is a respiratory specialist with a sub-specialist interest in airways disease - asthma, bronchiectasis and COPD. He runs a large programme of research developing new vaccines to prevent respiratory infections in patients with airways diseases.

He is a specialist consultant in the difficult airways disease clinic and COPD integrated service, and has developed new patient pathways for diagnosis and community based treatment for COPD.

Prof Wilkinson also leads a five year programme of NHS innovation and service improvement in integrated respiratory care across Wessex (NIHR CLAHRC).

Professor James D Chalmers studied medicine in Glasgow before medical training in South East Scotland. in 2008 he was awarded a Medical Research Council Training Fellowship to undertake a PhD into the immunology of bronchiectasis at the MRC Centre for Inflammation Research in Edinburgh. He moved to the University of Dundee in 2011 and established his independent research group in 2012. He was awarded a Wellcome Trust Postdoctoral Fellowship in Molecular Microbiology in 2013 and subsequently was awarded the GSK/British Lung Foundation Chair in Respiratory Research and a Senior Clinical Fellowship from the Scottish Government Chief Scientists Office in 2017.

Professor Chalmers is an active clinician running a specialist clinic for patients with difficult respiratory infections, particularly bronchiectasis, as an honorary consultant physician at Ninewells Hospital.

He has been recognised with a number of prestigious awards including the British Thoracic Society Early Career Investigator Award in 2011, the John Munro Medal for Excellence in Teaching from the Royal College of Physicians of Edinburgh in 2014, the Romain Pauwels Award for Scientific Achievements from the European Respiratory Society in 2017 and the Patrick Neil Medal from the Royal Society of Edinburgh. In 2021 he received the Cournand Lecture Award from the European Respiratory Society, the Mid-Career Peer Recognition Award from the American Thoracic Society and the Herald Higher Education Outstanding Contribution Award.

He has published more than 350 peer reviewed manuscripts and chaired several international guideline panels including the 2017 European Bronchiectasis Guidelines, the 2020 European Guidelines for ICS use in COPD, the European Respiratory Society Living Guideline for Management of Hospitalized Patients with COVID-19 and the upcoming European Respiratory Society Guidelines for the Management of Bronchiectasis in Adults. He was appointed as Deputy Chief Editor of the European Respiratory Journal and was appointed Chief Editor in 2018. He is current Chair of the Science and Research Committee of the British Thoracic Society and co-Chairs the Scottish Government Chief Scientist Office Translational Clinical Studies Committee.

Dr Anita Sharma is a Post-Doctoral Research Fellow at Royal Holloway, University of London. She has an interdisciplinary background in Sociology/Cultural studies and her research interests and expertise lie within the areas of race/ethnicity, cultural identity, multiculturalism, poverty, inequality, discrimination and disadvantage. Within her work, Anita has explored the intersections of race/ethnicity, gender, social class, and the importance of context in constructions of identity. She also has an interest in understanding change, continuity and differences between the ‘first’, ‘second’ and ‘third’ generations of ethnic minorities.

She has worked on ESRC and Leverhulme projects relating to ethnic minorities and retirement planning; different generations of women of the South Asian diaspora, pre- and post-retirement, examining their life course and how this can impact on wellbeing in later life. Most recently she has been involved in projects exploring digitalisation, the gig economy and platform labour, community wealth building, and food vulnerability. She has many years’ experience as a qualitative researcher and has worked collaboratively within Business Schools and Social Sciences’ faculties.

Now a Professor, Prof Hurst is Vice Dean (International) for the Faculty of Medical Sciences at University College London (UCL).

Prof. Hurst is an NIHR Global Research Professor (2024-2029).

Professor of Respiratory Medicine at UCL. Prof. Hurst graduated from the University of Edinburgh Medical School in 1997 and was appointed Senior Lecturer then Reader in Respiratory Medicine at UCL, and Honorary Consultant at Royal Free London NHS Foundation Trust in October 2007.

Prof Hurst is an Associate Editor at the European Respiratory Journal.

Previous national and international roles have included being the Non-Executive Director of an NHS Trust, Senior Clinical Lead to the UK National Asthma and COPD Audit Programme (NACAP), and Editor-in-Chief of the European Respiratory Monograph.

Shigeo Muro is a Professor in the Department of Respiratory Medicine at Nara Medical University in Japan. Professor, Faculty of Medicine/School of Medicine, Second Department of Internal Medicine, Nara Medical University Research Experience April 2018–present: Professor, Nara Medical University, Japan February 2001–March 2018: Department of Respiratory Medicine, Kyoto University, Japan July 1998–January 2001: McGill University, Meakins-Christie Laboratories, Canada April 1994–March 1998: Graduate school of medicine, Kyoto University, Japan

Mukesh is a GP Partner,Horse Fair Practice Group, Rugeley, GPwSI, Respiratory lead for Staffordshire & Stoke on Trent ICB, Tutor at Keele University Medical school, GP Trainer for West Midlands Deanery, Chair Staffordshire Respiratory Leaders Network and researcher. He is passionate about early and accurate diagnosis of respiratory illnesses in community and redesigning a suitable fit for purpose integrated service to optimise the care of these patients especially those who suffer from multi-morbidities. Mukesh has been actively involved in research and management of respiratory illnesses at both secondary and primary care levels. He enjoys his presentations of practice-based research on Respiratory illnesses specially asthma and chronic obstructive pulmonary disease (COPD) at various national and international conferences.

Professor Halpin trained at Oxford & St Thomas Hospital Medical School: completing a D.Phil. in the Department of Human Anatomy, Oxford, before finishing his clinical training at St Thomas. He completed his postgraduate training in respiratory medicine at the Brompton Hospital. Professor Halpin is a Fellow of Royal College Physicians, Member British Thoracic Society, European Respiratory Society & American Thoracic Society.   Professor Halpin continues to undertake research in respiratory medicine & has published widely. He lectures frequently around the world on COPD.   Until recently Professor Halpin was an Associate Editor of Thorax.   Professor Halpin is one of the 10 Directors of the WHO/NIH Global Initiative for Obstructive Lung Disease (GOLD) and a member of the GOLD Science Committee.   Professor Halpin was the Chairman and Clinical Expert for the COPD Guideline Development Group of the National Institute of Clinical Excellence (NICE) in the UK.   Until 2015 Professor Halpin was also Respiratory Clinical Lead for the NHS in the South West.

Dave Singh is Professor of Respiratory Pharmacology at the University of Manchester.

He graduated from Cambridge University and went on to train in medicine and clinical pharmacology in Manchester, which included working in industry on early phase clinical trials. His research interests are in the pharmacotherapy of Asthma and COPD, with studies spanning from basic pharmacology of anti-inflammatory drugs to clinical trials.

He has acted as Principal Investigator on numerous clinical trials of novel therapies in asthma and COPD, and has over 200 publications in peer reviewed journals. He is a member of the GOLD Science Committee.

Dr. Dransfield is Professor of Medicine and the Director of the Division of Pulmonary, Allergy and Critical Care. He completed his medical degree at the University of North Carolina at Chapel Hill in 1997, followed by residency in internal medicine and fellowship training in pulmonary and critical care medicine at the University of Alabama at Birmingham, where he served as Chief Fellow. He has been on the faculty at UAB since 2003. Dr. Dransfield is also the Ben Branscomb Endowed Chair in Pulmonary Disease and the Medical Director of the UAB Lung Health Center and a member of the both the American Society of Clinical Investigation and Southern Society of Clinical Investigation. Dr. Dransfield's primary clinical interests include chronic obstructive pulmonary disease (COPD) and lung cancer.

Tonya A Winders, MBA, is the President and Chief Executive Officer of Allergy & Asthma Network, a patient advocacy organization dedicated to ending suffering due to asthma, allergies and related conditions. She has over 20 years of experience in leadership roles within the allergy and asthma industry. Tonya has co-authored over 30 peer-reviewed articles and serves on several expert panels including the American Thoracic Society Public Advisory Roundtable and GINA international guidelines. She is on the board of directors for the Alliance to Prevent Legionnaires Disease and the American Respiratory Care Foundation and is the current president of the Global Allergy & Airways Patient Platform (GAAPP), representing over 60 patient organizations throughout the world.

Mona Bafadhel is the Director of the new King’s Centre for Lung Health, and the Chair of Respiratory Medicine at King’s College London. She is also a consultant respiratory physician with a clinical and research interest in chronic obstructive lung disease (COPD) and asthma. Mona is an international academic leader in respiratory medicine, with a passion for translating science to clinical practice to improve outcomes for patients. Her work in COPD and COVID-19 has translated to changing clinical practice affecting millions across the world. In 2018, Mona was awarded the Goulstonian Lectureship from the Royal College of Physicians for excellence in the Clinical Sciences. She is only the 4th woman and the 1st from an ethnic minority in the Royal College of Physician near 400 year history to have achieved this accolade. Mona was appointed as co-lead of the King’s Health Partners Respiratory & Allergy Clinical Academic Group in March 2022.

Specific Research Interests: Chronic Obstructive Lung Disease (COPD) Exacerbations Asthma and Airways Disease Endotypes Eosinophils Airway Inflammation Translational Respiratory Medicine